[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2015 Edition

January 2015 | 52 pages | ID: G10FCD21AEFEN
Koncept Analytics

US$ 800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic stenosis). It is sometimes also called transcatheter aortic valve implantation (TAVI). Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery. As a result, the market of heart valve surgical procedures is witnessing a continuous decline as more and more patients requiring valve replacement are at risk for a surgical treatment. This shortcoming of the traditional surgical method has paved way for the popularity and adoption of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market for TAVR is regarded to be promising with immense growth opportunities and unmet demand to cater to.

The key factors which are anticipated to drive market growth include ageing population, healthcare expenditure, increasing obese population and gross domestic product apart from increasing prevalence of inoperable aortic stenosis. Some of the noteworthy developments of this industry include advancement in technologies and favorable reimbursement in Europe. However, the industry remains threatened by certain challenges which include regulatory issues, associated high risk and high cost of TAVR devices.

This report offers a comprehensive analysis of the global TAVR market, along with an in-depth study of the TAVR procedures and the regional markets of the US, Europe and Japan. The global TAVR market is dominated by two major players, Edwards Lifesciences and Medtronic which operate in a highly dynamic environment working in the direction of tapping maximum market share. Both the companies in addition to St. Jude Medical have been profiled in the present report highlighting their key financials and business strategies for growth.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables affecting this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. MARKET OVERVIEW

2. TAVR MARKET ANALYSIS

2.1 Global Market
  Market Value
  Regional Breakdown
2.2 Regional Markets
  2.2.1 The US
    Market Value
    Volume
    Transapical vs. Transfemoral
    TAVR Centers
    Price Trend
  2.2.2 Europe/ROW
    Market Value
    Procedure Volume
    Price Trend
  2.2.3 Japan
    Market Value
    Procedure Volume

3. MARKET DYNAMICS

3.1 Growth Drivers
  3.1.1 Increasing Global Ageing Population
  3.1.2 Rising Global Healthcare Expense
  3.1.3 Increasing Obese Population
  3.1.4 Global Economic Development
  3.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
3.2 Challenges
  3.2.1 Regulatory Issues
  3.2.2 Associated High Risk
  3.2.3 High Cost of TAVR Devices
3.3 Key Trends
  3.3.1 Technological Advancements
  3.3.2 Favorable Reimbursement in Europe

4. COMPETITIVE LANDSCAPE

4.1 Global
  Market Share
  Implants by Company
  TAVR Centers by Company
4.2 US
  Market Share
  Implants by Company
4.3 Outside US
  Market Share
  Implants by Company
  TAVR Centers by Company
  4.3.1 Europe
  4.3.2 Japan

5. COMPANY PROFILES

5.1 Edwards lifesciences
  5.1.1 Business Overview
  5.1.2 Financial Overview
  5.1.3 Business Strategies
    Research & Development
    Offer Innovative Technologies
5.2 Medtronic
  5.2.1 Business Overview
  5.2.2 Financial Overview
  5.2.3 Business Strategies
    Focus on Research & Development
    Strategic Business Acquisitions
5.3 St. Jude Medical
  5.3.1 Business Overview
  5.3.2 Financial Overview
  5.3.3 Business Strategies
    Innovation Initiatives
    Strengthen Through Acquisitions

6. MARKET OUTLOOK

6.1 Market Forecast
6.2 Forecast Methodology
  6.2.1 Dependent and Independent Variables
  6.2.2 Correlation Analysis
  6.2.3 Regression Analysis

LIST OF CHARTS

Global Transcatheter Aortic Valve Replacement (TAVR) Procedure
Global TAVR Market Value (2009-2013)
TAVR Market by Region (2014)
The US TAVR Market Value and Penetration (2011-2017E)
The US TAVR Procedures (2011-2017E)
The US TAVR Procedures - Transapical vs. Transfemoral (2011-2017E)
TAVR Centers in the US (2011-2017E)
Average Selling Price of TAVR in the US (2011-2017E)
Europe/ROW TAVR Market Value and Penetration (2010-2017E)
Europe/ROW TAVR Procedures (2010-2017E)
Average Selling Price of TAVR in Europe/ROW (2010-2017E)
Japanese TAVR Market Value and Penetration (2013-2017E)
Japanese TAVR Procedures (2013-2017E)
Global Ageing Population Over 65 (2009-2013)
Global Health Care Expenditure Per Capita (2008-2013E)
Global Obese Population (2009-2013E)
World GDP (2009-2013)
Global TAVR Market Share by Company (2013)
Global TAVR Market – Implanting Centers by Company (2011–2014E)
Global TAVR Market – Average Selling Price by Company (2011–2014E)
The US TAVR Market Share by Company (2013)
Outside US TAVR Market Share by Company (2013)
OUS TAVR Market – Implanting Centers by Company (2011–2014E)
OUS TAVR Market – Average Selling Price by Company (2011–2014E)
European TAVR Market Share by Company (2013)
Japanese TAVR Market Share by Company (2013)
Edwards Lifesciences Revenue Share by Product Group (2013)
Edwards Lifesciences Revenue and Net Income (2009-2013)
Medtronic’s Revenue Share by Business Units (2014)
Medtronic’s Revenue and Net Income (2010-2014)
St. Jude Medical Revenue by Divisions (2013)
St. Jude Medical’s Revenue and Net Income (2009-2013)
Transcatheter Aortic Valve Replacement Market Forecast (2013-2017F)

LIST OF TABLES

TAVR Competitive Landscape
Global TAVR Market – Total Implants by Company (2011-2014E)
The US TAVR Market – Total Implants by Company (2011-2014E)
OUS TAVR Market – Total Implants by Company (2011-2014E)
Dependent & Independent Variables (2009– 2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output


More Publications